当前位置: 首页 > 期刊 > 《中华肿瘤杂志》 > 1998年第4期
编号:10651982
动脉插管化疗治疗中晚期膀胱肿瘤(附11例报告)
http://www.100md.com 《中华肿瘤杂志》 1998年第4期
膀胱肿瘤,药物疗法|顺铂,治疗应用|丝裂霉素,治疗应用|长春新碱,治疗应用|介入性治疗,关键词:
     李青 许学敏 刘俊敏 100029 北京安贞医院泌尿外科 中华肿瘤杂志 1998 0 0 4


    关键词:膀胱肿瘤/药物疗法;顺铂/治疗应用;丝裂霉素/治疗应用;长春新碱/治疗应用;介入性治疗 期刊 zhzlzz 0 临床研究 fur -->


    

摘要 目的 探讨动脉插管化疗对于中晚期膀胱肿瘤的治疗效果。方法 对 11例由于年龄大、体质差、发现较晚、不能耐受麻醉和手术的中晚期膀胱肿瘤患者,采用了动脉插管化疗。结果 11例患者治疗后平均存活时间为 26.2±13.1个月, 1年生存率为 81.8%,总有效率为 90.9%,不良反应轻微。结论 动脉插管化疗是目前治疗中晚期膀胱肿瘤的一种较好方法。

    Arterial infusion chemotherapy forpatients with advanced and moderately advanced cancer of urinary bladder Li Qing, Xu Xuemin, Liu Junmin. Department of Urology, Anzhen Hospital, Beijing 100029

    【 Abstract Objective To study the effect of arterialinfusion chemotherapy in patients with carcinoma of urinary bladder. Methods Eleven patients with advanced ormoderately advanced cancer of the urinary bladder (10 transitional cell carcinoma, 1 squamous-cell carcinoma) who were for various reasons not suitable for surgical treatmentwere treated by arterial infusion chemotherapy according to Seldinger′s percutaneous approach. Results The treatment results weresatisfactory with an overall response rate of 90.9% (CR=2, PR=8). The average survivaltime of the 11 patients was 26.2±13.1 months. The 1-year survival rate was 81.8%. Sideeffects were mild. Conclusion Arterial infusion chemotherapy is of use in patients withadvanced or moderately advanced bladder cancer.

     ......


您现在查看是摘要页,全文长 14947 字符